
INTC · Nasdaq
Expected to report Oct 22, 2026 — estimated from last year’s reporting date.
Consensus is $0.28 EPS for Sep 2026 across 11 estimates, ranging $0.27 to $0.30.
Intel's Q2 FY2026 was a sharp operating rebound, led by AI-related data-center demand, pricing and better factory execution. Revenue of $16.13 billion increased 25% from $12.86 billion a year earlier and 19% from Q1's $13.58 billion. The supplied expectation set lists reported EPS of $0.30 against a $0.10 consensus, a 200% surprise; Intel's release reported non-GAAP EPS of $0.42 and GAAP EPS of negative $2.16. Operating income improved to $1.80 billion from a $3.18 billion loss a year ago and a $3.14 billion loss in Q1, while non-GAAP operating income was $2.77 billion.
The core print was the strength of Intel Products: DCAI revenue rose 59% to $6.26 billion and CCPG revenue increased 13% to $8.88 billion, lifting segment operating income to $4.82 billion from $2.69 billion. Gross margin expanded 12.9 percentage points year over year to 40.4%, helped by higher product profit and fewer impairment and restructuring charges. However, GAAP earnings were overwhelmed by a $12.5 billion non-cash mark-to-market loss on government Escrowed Shares. Foundry growth remains principally internal, with $5.77 billion of revenue but a $2.09 billion operating loss, while Intel increased capacity commitments and completed a $14.2 billion Ireland SCIP buyout.
The quarter showed a meaningful improvement in the underlying cost structure. Gross profit increased 84% to $6.51 billion, with gross margin rising to 40.4% from 27.5% a year earlier. Intel attributed the improvement to $1.5 billion of higher product profit and $1.5 billion of lower period charges, including the absence of the $797 million of manufacturing-asset impairment and accelerated depreciation recorded in Q2 2025. R&D and MG&A fell 6% to $4.54 billion, helped by headcount reductions and cost controls. Restructuring charges declined to $170 million from $1.89 billion, though an inventory-related charge was recorded to align product mix with customer demand.
Intel Foundry revenue rose 31% to $5.77 billion, primarily from higher internal wafer volumes on Intel 18A, Intel 3 and Intel 4. The segment's operating loss narrowed to $2.09 billion from $3.17 billion, but the business remains structurally loss-making: external revenue was just $293 million, versus $5.47 billion of intersegment revenue. Intel entered risk production for 18A-P, began high-volume manufacturing for a subset of Panther Lake processors using ASML High NA EUV, and committed to a €5 billion expansion for Xeon capacity. Management said the pace of further 14A expansion will depend on committed internal demand and external design wins.
The headline GAAP loss does not reflect the quarter's operating result. Intel recognized a $12.5 billion loss from the increase in fair value of Escrowed Shares associated with its Secure Enclave agreement with the U.S. government. That charge was recorded in interest and other, net, which swung to a $12.58 billion expense from a $95 million expense in Q2 2025. The related derivative liability was $15.6 billion at quarter end, compared with $2.7 billion at year-end 2025. Intel released 7 million shares during the quarter and had 143 million Escrowed Shares not yet released at June 27.
Intel repurchased Apollo's 49% interest in Ireland SCIP for $14.2 billion, funded with cash, investments and temporary borrowing. It issued $6.5 billion of senior notes and repaid a $6.5 billion term loan during the quarter. Six-month operating cash flow was $8.10 billion, but adjusted free cash flow was negative $8.42 billion after capital spending, finance-lease payments and net partner contributions, including the Ireland SCIP distribution. Cash and short-term investments totaled $29.73 billion at quarter end, versus $37.42 billion at December 2025, while debt increased to $48.55 billion from $44.09 billion.
Intel expects Q3 revenue of $15.8 billion-$16.8 billion, implying a midpoint of $16.3 billion, broadly in line with Q2's $16.13 billion. The outlook calls for 41.0% GAAP gross margin, 42.0% non-GAAP gross margin, GAAP EPS of $0.31 and non-GAAP EPS of $0.38. The forecast embeds continued demand strength but also ongoing supply constraints, capacity investment and the cost of ramping newer process technologies.